Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib
- Resource Type
- Abstract
- Authors
- Yimer, Habte; Rifkin, Robert; Noga, Stephen; Manda, Sudhir; Birhiray, Ruemu; Yasenchak, Christopher; Lyons, Roger; Kelly, Peter; Chojnicki, Eric; Whidden, Presley; Wang, Bingxia; Demers, Brittany; Dollar, Larry; Boccia, Ralph
- Source
- In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e11-e11
- Subject
- Language
- ISSN
- 2152-2650